Source:http://linkedlifedata.com/resource/chembl/assay/description
| Subject | Predicate | Object | Context |
|---|---|---|---|
| assay:41573 | assay:description | Butyrylcholinesterase | lld:chembl |
| assay:48195 | assay:description | Corticosteroid binding globulin | lld:chembl |
| assay:1 | assay:description | The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM | lld:chembl |
| assay:2 | assay:description | Compound was evaluated for its ability to mobilize calcium in 1321NI cells | lld:chembl |
| assay:4 | assay:description | Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680 | lld:chembl |
| assay:5 | assay:description | In vitro cell cytotoxicity against 143-B cell lines(Human osteosarcoma cell line) | lld:chembl |
| assay:6 | assay:description | In vitro cell cytotoxicity against 143-B cell lines(Human osteosarcoma cell line) | lld:chembl |
| assay:7 | assay:description | Cytotoxic Activity was evaluated against 143B (TK-) tumor cells | lld:chembl |
| assay:8 | assay:description | In vitro cell cytotoxicity was determined against 143B cell line | lld:chembl |
| assay:9 | assay:description | Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound | lld:chembl |
| assay:10 | assay:description | In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK | lld:chembl |
| assay:11 | assay:description | In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK | lld:chembl |
| assay:12 | assay:description | In vitro cell cytotoxicity was determined against 143B-LTK cell line | lld:chembl |
| assay:13 | assay:description | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | lld:chembl |
| assay:14 | assay:description | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | lld:chembl |
| assay:15 | assay:description | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | lld:chembl |
| assay:16 | assay:description | The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus | lld:chembl |
| assay:17 | assay:description | Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase | lld:chembl |
| assay:18 | assay:description | Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO) | lld:chembl |
| assay:19 | assay:description | Inhibition of partially purified 15-lipoxygenase from human leukocytes | lld:chembl |
| assay:20 | assay:description | Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO) | lld:chembl |
| assay:22 | assay:description | Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO) | lld:chembl |
| assay:21 | assay:description | Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO) | lld:chembl |
| assay:23 | assay:description | Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO) ;NI is no inhibition | lld:chembl |
| assay:24 | assay:description | Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition | lld:chembl |
| assay:25 | assay:description | Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M. | lld:chembl |
| assay:26 | assay:description | In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase | lld:chembl |
| assay:27 | assay:description | Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM) | lld:chembl |
| assay:28 | assay:description | Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes | lld:chembl |
| assay:29 | assay:description | Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean | lld:chembl |
| assay:30 | assay:description | Inhibitory activity against soybean 15-lipoxygenase was evaluated | lld:chembl |
| assay:31 | assay:description | Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM | lld:chembl |
| assay:32 | assay:description | The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM | lld:chembl |
| assay:33 | assay:description | The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM | lld:chembl |
| assay:34 | assay:description | Compound was tested in vitro for inhibition of 15-lipoxygenase soybean | lld:chembl |
| assay:35 | assay:description | Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean | lld:chembl |
| assay:36 | assay:description | Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase | lld:chembl |
| assay:37 | assay:description | Binding affinity against bacterial 16S rRNA using mass spectrometry based assay | lld:chembl |
| assay:38 | assay:description | Dissociation constant with dimeric 16S rRNA RNA construct B | lld:chembl |
| assay:39 | assay:description | Dissociation constant towards 16S rRNA construct A | lld:chembl |
| assay:40 | assay:description | Dissociation constant towards 16S rRNA construct B | lld:chembl |
| assay:41 | assay:description | Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli | lld:chembl |
| assay:42 | assay:description | Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli | lld:chembl |
| assay:43 | assay:description | Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2) | lld:chembl |
| assay:51 | assay:description | Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2) | lld:chembl |
| assay:44 | assay:description | Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2) | lld:chembl |
| assay:45 | assay:description | The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes | lld:chembl |
| assay:46 | assay:description | The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes | lld:chembl |
| assay:47 | assay:description | Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation | lld:chembl |
| assay:48 | assay:description | Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation | lld:chembl |
| assay:49 | assay:description | Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM | lld:chembl |
| assay:50 | assay:description | Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM | lld:chembl |
| assay:52 | assay:description | Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) | lld:chembl |
| assay:53 | assay:description | Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration | lld:chembl |
| assay:54 | assay:description | Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration | lld:chembl |
| assay:55 | assay:description | Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes | lld:chembl |
| assay:149306 | assay:description | Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes | lld:chembl |
| assay:56 | assay:description | Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined | lld:chembl |
| assay:57 | assay:description | Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype | lld:chembl |
| assay:58 | assay:description | Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor | lld:chembl |
| assay:59 | assay:description | Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor | lld:chembl |
| assay:60 | assay:description | In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation | lld:chembl |
| assay:61 | assay:description | In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation | lld:chembl |
| assay:62 | assay:description | Cytotoxic activity against human ovarian cancer (1A9) cell line | lld:chembl |
| assay:63 | assay:description | Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined | lld:chembl |
| assay:64 | assay:description | Effective dose of compound against replication of 1A9 cell line was evaluated | lld:chembl |
| assay:65 | assay:description | In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line | lld:chembl |
| assay:66 | assay:description | In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line) | lld:chembl |
| assay:67 | assay:description | In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active | lld:chembl |
| assay:68 | assay:description | In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL | lld:chembl |
| assay:69 | assay:description | Inhibitory activity against Taxol resistant 1A9 cell lines | lld:chembl |
| assay:70 | assay:description | Cytotoxicity against human ovarian cancer (1A9) cell lines. | lld:chembl |
| assay:71 | assay:description | Percentage inhibition of human ovarian cancer (1A9) cell lines. | lld:chembl |
| assay:72 | assay:description | Effective dose required for inhibitory activity against 1A9 human tumor cell line. | lld:chembl |
| assay:73 | assay:description | Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL | lld:chembl |
| assay:74 | assay:description | Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL | lld:chembl |
| assay:75 | assay:description | Percent inhibition against 1A9 human tumor cell line at >10 ug/mL | lld:chembl |
| assay:76 | assay:description | Inhibitory concentration against Jurkat cells | lld:chembl |
| assay:92487 | assay:description | Inhibitory concentration against Jurkat cells | lld:chembl |
| assay:77 | assay:description | In vitro anticancer activity against 2 SCLC cell line; inactive | lld:chembl |
| assay:78 | assay:description | Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase | lld:chembl |
| assay:79 | assay:description | In vitro inhibition of human 2,3-oxidosqualene cyclase. | lld:chembl |
| assay:80 | assay:description | In vitro inhibition of human 2,3-oxidosqualene cyclase. | lld:chembl |
| assay:81 | assay:description | In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM. | lld:chembl |
| assay:82 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes | lld:chembl |
| assay:83 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes | lld:chembl |
| assay:84 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes | lld:chembl |
| assay:85 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes | lld:chembl |
| assay:86 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes | lld:chembl |
| assay:87 | assay:description | Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase | lld:chembl |
| assay:88 | assay:description | Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC) | lld:chembl |
| assay:89 | assay:description | Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki | lld:chembl |
| assay:90 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes | lld:chembl |
| assay:91 | assay:description | Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes | lld:chembl |
| assay:92 | assay:description | Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes | lld:chembl |
| assay:93 | assay:description | Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease) | lld:chembl |
| assay:94 | assay:description | Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex | lld:chembl |
| assay:95 | assay:description | In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line | lld:chembl |
| assay:96 | assay:description | 50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line. | lld:chembl |
| assay:97 | assay:description | Antiviral activity against Hepatitis B virus in 2.2.15 cell line | lld:chembl |